ArticleBone marrow transplantation2015

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study.

E Nikolousis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.